Albumin downregulates Klotho in tubular cells

Beatriz Fernandez-Fernandez1,2,3, M Concepcion Izquierdo1,2,3, Lara Valiño-Rivas1,2,3

  • 1Department of Nephrology, IIS-Fundación Jiménez Díaz-Universidad Autónoma de Madrid, Madrid, Spain.

Insights

Albuminuria directly reduces Klotho protein in kidney tubular cells, contributing to cardiovascular aging in early chronic kidney disease (CKD). This finding explains Klotho deficiency in patients with normal kidney function but high albumin levels.

Area of Science:

  • Nephrology
  • Cardiovascular Aging
  • Molecular Biology

Background:

  • Kidney tubular cells produce Klotho, a protein crucial for regulating phosphate and preventing premature cardiovascular aging.
  • Genetic Klotho deficiency in mice leads to accelerated cardiovascular aging.
  • Acquired Klotho deficiency is a hallmark of human chronic kidney disease (CKD), even in early stages (G1 CKD) with normal glomerular filtration rate (GFR) and without significant uremic toxin buildup.

Purpose of the Study:

  • To investigate if albuminuria, a marker for early CKD, directly diminishes Klotho expression.
  • To explore this effect in human CKD patients, preclinical animal models, and cell cultures.

Main Methods:

  • Correlated albuminuria with serum phosphate in a CKD cohort, adjusting for GFR, age, and sex.
  • Induced proteinuria in rats and mice to assess kidney Klotho messenger ribonucleic acid (mRNA) and protein levels.
  • Utilized Western blot and immunohistochemistry to quantify and localize Klotho expression in kidneys.
  • Exposed cultured human and murine tubular cells to albumin and measured Klotho mRNA and protein changes.
  • Investigated the role of histone deacetylase (HDAC) inhibition (trichostatin A) and nuclear factor kappa-light-chain-enhancer of activated B cells (NF-κB) inhibition.

Main Results:

  • Albuminuria correlated with higher serum phosphate in CKD patients, independent of GFR.
  • Urinary Klotho levels were reduced in patients with pathological albuminuria but preserved GFR.
  • Proteinuric animal models showed interstitial inflammation and decreased kidney Klotho mRNA and protein, localized to tubular cells.
  • In vitro, albumin directly reduced Klotho mRNA and protein expression in tubular cells.
  • Albumin-induced Klotho downregulation was mitigated by HDAC inhibition but not NF-κB inhibition.

Conclusions:

  • Albumin directly suppresses Klotho expression in kidney tubular cells.
  • This mechanism likely contributes to Klotho deficiency observed in early CKD stages.
  • The findings may explain fibroblast growth factor 23 (FGF23) resistance in proteinuric kidney disease.
Abstract

Related Concept Videos

Receptor Downregulation in MVBs01:15

Receptor Downregulation in MVBs

Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that  lead to cell proliferation, migration, and differentiation. Overexpression of EGFR  stimulates cells to proliferate. Excessive  EGFR...
2.9K
Vesicular Tubular Clusters01:45

Vesicular Tubular Clusters

After budding out from the ER membrane, some COPII vesicles lose their coat and fuse with one another to form larger vesicles and interconnected tubules called vesicular tubular clusters or VTCs. These clusters constitute a compartment at the ER-Golgi interface known as ERGIC (Endoplasmic Reticulum Golgi Intermediate Compartment). The ERGIC is a mobile membrane-bound cargo transport system that sorts proteins secreted from ER and delivers them to the Golgi.
With the help of motor proteins such...
3.3K
Tubular Reabsorption and Secretion01:28

Tubular Reabsorption and Secretion

Tubular secretion and reabsorption are two critical processes in the nephron tubule of the kidneys. When the fluid filtered from the glomerulus enters the proximal convoluted tubule, it is referred to as filtrate, and its composition changes due to tubular reabsorption and secretion.
Tubular reabsorption is a selective process that starts when the filtrate enters the proximal tubules. It involves substances traveling through the transcellular route (through the tubule cell and peritubular...
7.0K
Physiology of the Genitourinary System II: Tubular Reabsorption and Secretion01:22

Physiology of the Genitourinary System II: Tubular Reabsorption and Secretion

The kidneys maintain homeostasis through filtration, reabsorption, and secretion. Tubular reabsorption and secretion are crucial in forming urine and regulating electrolytes, water balance, and waste elimination.Tubular Reabsorption and Secretion ProcessesTubular reabsorption is the process that reclaims essential substances such as electrolytes, glucose, amino acids, and water from the glomerular filtrate back into the bloodstream. This is achieved through passive and active transport...
1.4K
Renal Drug Excretion: Tubular Reabsorption01:25

Renal Drug Excretion: Tubular Reabsorption

Tubular reabsorption, a process occurring post-glomerular filtration of drugs in the renal tubule, is a critical determinant of drug half-life. During the process of renal excretion, as the glomerular filtrate progresses to the distal convoluted tubule (DCT), drugs that are highly permeable, lipophilic, and nonionized undergo passive reabsorption from the tubular fluid into the surrounding peritubular capillaries. This reabsorption process restricts their elimination through the kidneys. This...
908
Renal Drug Excretion: Tubular Secretion01:28

Renal Drug Excretion: Tubular Secretion

Active tubular secretion is a robust, energy-demanding process that utilizes carrier systems to transport drugs into renal tubules. The active renal secretion systems include the organic anion transporter (OAT) for weak acids and the organic cation transporter (OCT) for weak bases. Structurally similar drugs can compete for the same transporter, potentially leading to drug accumulation and toxicity. However, this principle can be exploited therapeutically. One example is probenecid (Probalan),...
942